← Leaderboards
William Paul Duprex
Icahn School Of Medicine At Mount Sinai
$23,556,651
Attributed
$25,337,552
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.5M · FY2011–25$20M$15M$10M$5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,397,444 · 12
By mechanism
UC7$16,327,635 · 7
G20$6,659,737 · 1
U19$5,674,171 · 1
R01$4,515,359 · 2
R21$220,542 · 1
Top collaborators
- Yi Shi4 shared
- Cheng Zhang4 shared
- Katharine Nina Bossart2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Yi Shi$3,269,966
- Cheng Zhang$6,068,855
- Jean Kyou Lim$13,225,849
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsInfectionPathogenIn VivoPathogenesisProgramsPandemic DiseaseCellsBiologicalEmerging Communicable DiseasesViralEnsureLaboratoriesOperationEmerging PathogenEventUniversitiesBiodefensePandemic PreparednessTransmission ProcessComplexResponseBiologyResearch Personnel
Grant awards (29)
Pitt RBL$2,594,826
UC7 · FY2025 · AI · contact PI
Operations Core$982,724
UC7 · FY2025 · AI · contact PI
Integrated Services Core$895,766
UC7 · FY2025 · AI · contact PI
Practices Core$716,336
UC7 · FY2025 · AI · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$535,044
R01 · FY2025 · AI
Prototype strategy for vaccines and antibodies to rubulaviruses$5,674,171
U19 · FY2024 · AI · contact PI
Pitt RBL$2,594,826
UC7 · FY2024 · AI · contact PI
Operations Core$1,006,216
UC7 · FY2024 · AI · contact PI
Integrated Services Core$879,285
UC7 · FY2024 · AI · contact PI
Practices Core$709,325
UC7 · FY2024 · AI · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$587,096
R01 · FY2024 · AI
Pitt RBL$2,870,240
UC7 · FY2023 · AI · contact PI
Integrated Services Core$1,158,560
UC7 · FY2023 · AI · contact PI
Operations Core$984,552
UC7 · FY2023 · AI · contact PI
Practices Core$727,128
UC7 · FY2023 · AI · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$614,795
R01 · FY2023 · AI
Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research$3,329,737
G20 · FY2022 · AI · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$769,010
R01 · FY2022 · AI
Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research$3,330,000
G20 · FY2021 · AI · contact PI
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation$409,250
R01 · FY2017 · AI · contact PI
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation$409,250
R01 · FY2016 · AI · contact PI
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation$409,250
R01 · FY2015 · AI · contact PI
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation$404,154
R01 · FY2014 · AI · contact PI
Shifting a Paradigm in Vaccine Safety: From Empirical to Rational Attenuation$377,510
R01 · FY2013 · AI · contact PI
Cell and Tissue Imaging Core$29,152
UC7 · FY2013 · AI · contact PI
Multimodal imaging of antibody-mediated therapy during acute viral encephalitides$22,035
R21 · FY2013 · AI
Multimodal imaging of antibody-mediated therapy during acute viral encephalitides$198,507
R21 · FY2012 · AI
Cell and Tissue Imaging Core$107,808
UC7 · FY2012 · AI · contact PI
Cell and Tissue Imaging Core$70,891
UC7 · FY2011 · AI · contact PI